SCHEMBL408067

SCHEMBL408067

Cc1cc(F)ccc1B(O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.41
ORAI1 Q96D31 1/20 0.37
ORAI2 Q96SN7 1/20 0.37
ORAI3 Q9BRQ5 1/20 0.37
TRPV6 Q9H1D0 1/20 0.37
CA3 P07451 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35
ALOX5 P09917 1/20 0.35
HDAC4 P56524 1/20 0.34
RAPGEF4 Q8WZA2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CES2 O00748 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29426963 1.00 ACHE (0.41) ACHEORAI1ORAI2ORAI3TRPV6
SCHEMBL19171232 0.88 ORAI1 (0.41) ACHEORAI1ORAI2ORAI3TRPV6
SCHEMBL19726536 0.83 ACHE (0.38) ACHECA3CA6CA5ACA9
SCHEMBL31555013 0.81 ACHE (0.41) ACHEORAI1ORAI2ORAI3TRPV6
SCHEMBL337813 0.81 ACHE (0.41) ACHEORAI1ORAI2ORAI3TRPV6
SCHEMBL10213841 0.81 ACHE (0.36) ACHECA3CA6CA5ACA9
SCHEMBL257792 0.80 ESR2 (0.53) ACHE
SCHEMBL19172382 0.78 ORAI1 (0.33) ORAI1ORAI2ORAI3TRPV6
SCHEMBL39406 0.78 CES2 (0.43) ACHEORAI1ORAI2ORAI3TRPV6
SCHEMBL29395656 0.78 CES2 (0.43) ACHEORAI1ORAI2ORAI3TRPV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 887 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473260-B2 Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814 KaNDy Therapeutics Limited (GB) 2025-11-18 US claimed
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
CN-114728906-B Novel chemical process for preparing the key intermediate 6-chloro-4- (4-fluoro-2-methylphenyl) pyridin-3-amine of NT-814 康堤医疗有限公司 2024-08-20 CN claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
US-20230002322-A1 NEW CHEMICAL PROCESS FOR MAKING 6-CHLORO-4-(4-FLUORO-2-METHYLPHENYL)PYRIDIN-3-AMINE A KEY INTERMEDIATE OF NT-814 KaNDy Therapeutics Limited (GB) 2023-01-05 US claimed
US-20220225646-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
CN-114728906-A Novel chemical method for preparing key intermediate 6-chloro-4- (4-fluoro-2-methylphenyl) pyridine-3-amine of NT-814 康堤医疗有限公司 2022-07-08 CN claimed
WO-2021094247-A1 NEW CHEMICAL PROCESS FOR MAKING 6-CHLORO-4-(4-FLUORO-2-METHYLPHENYL)PYRIDIN-3-AMINE A KEY INTERMEDIATE OF NT-814 KaNDy Therapeutics Limited (GB) 2021-05-20 WO claimed
US-10457695-B2 Process for the preparation of tavaborole GLENMARK LIFE SCIENCES LIMITED (IN) 2019-10-29 US claimed
US-20190023724-A1 PROCESS FOR THE PREPARATION OF TAVABOROLE ALIVUS LIFE SCIENCES LIMITED (IN) 2019-01-24 US claimed
WO-2017125835-A1 PROCESS FOR PREPARATION OF TAVABOROLE GLENMARK PHARMACEUTICALS LIMITED (IN) 2017-07-27 WO claimed
CN-103289033-A Aryl boron-containing phenolic resin and preparation method thereof UNIV XI AN JIAOTONG 2013-09-11 CN claimed
US-8361484-B2 Polymer systems for lung volume reduction therapy AERIS THERAPEUTICS, INC. (US) 2013-01-29 US claimed
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy CANADIAN IMPERIAL BANK OF COMMERCE (CA) 2010-02-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023724-A1 PROCESS FOR THE PREPARATION OF TAVABOROLE VPS4B, SQLE, F5 ACHE 4631/4885ORAI1 2753/4885ORAI2 1152/4885
US-20230002322-A1 NEW CHEMICAL PROCESS FOR MAKING 6-CHLORO-4-(4-FLUORO-2-METHYLPHENYL)PYRIDIN-3-AMINE A KEY INTERMEDIATE OF NT-814 NT5E, NT5M, NTRK2 ACHE 317/4885ORAI1 3679/4885ORAI2 4243/4885
US-10457695-B2 Process for the preparation of tavaborole VPS4B, SQLE, F5 ACHE 4631/4885ORAI1 2753/4885ORAI2 1152/4885
US-20100040538-A1 Polymer Systems for Lung Volume Reduction Therapy GFER, MUC1, CTH ACHE 2517/4885ORAI1 3414/4885ORAI2 4022/4885
US-12473260-B2 Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814 NT5E, NT5M, NTRK2 ACHE 264/4885ORAI1 3542/4885ORAI2 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.